Photodynamic therapy vs. imiquimod 5% cream as skin cancer preventive strategies in patients with field changes: A randomized intraindividual comparison study

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 2, 2015, Pages 325-329

  Sotiriou, E ^a   Apalla, Z ^a   Vrani, F ^a   Lallas, A ^a   Chovarda, E ^a   Ioannides, D ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; IMIQUIMOD; PARACETAMOL; AMINOQUINOLINE DERIVATIVE; IMMUNOLOGICAL ADJUVANT;

ADULT; AGED; ARTICLE; BURN; CANCER PREVENTION; CLINICAL ARTICLE; CONTROLLED STUDY; CREAM; CRYOTHERAPY; DRUG EFFICACY; DRUG SAFETY; EROSION; ERYTHEMA; FACE; FEMALE; FOLLOW UP; HUMAN; INFLUENZA; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PAIN; PATIENT PREFERENCE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCALP; SKIN CANCER; SKIN EDEMA; STINGING SENSATION; TREATMENT DURATION; VERY ELDERLY; COMPARATIVE STUDY; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS; TOPICAL DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, TOPICAL; AGED; AMINOQUINOLINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS;

EID: 84921559033     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12538     Document Type: Article

References (35)

1. Trakatelli M, Ulrich C, del Marmol V, et al,. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007; 156 (Suppl. 3): 1-7.
2. Röwert-Huber J, Patel MJ, Forschner T, et al,. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 2007; 156 (Suppl. 3): 8-12.
3. Berman B, Cohen DE, Amini S,. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents. Cutis 2012; 89: 241-250.
4. Moy RL,. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42 (1 Pt 2): 8-10.
5. Cockerell CJ,. Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). J Am Acad Dermatol 2000; 42 (1 Pt 2): 11-17.
6. Ackerman AB, Mones JM,. Solar (actinic) keratosis is squamous cell carcinoma. Br J Dermatol 2006; 155: 9-22.
7. Braakhuis BJM, Tabor MP, Kummer JA, et al,. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-1730.
8. Carlson JA, Scott D, Wharton J, et al,. Incidental histopathologic patterns: possible evidence of 'field cancerization' surrounding skin tumors. Am J Dermatopathol 2001; 23: 494-496.
9. Slaughter DP, Southwick HW, Smejkal W,. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953; 6: 963-968.
10. Dakubo GD, Jakupciak JP, Birch-Machin MA, et al,. Clinical implications and utility of field cancerization. Cancer Cell Int 2007; 7: 2.
11. Stern RS, Bolshakov S, Nataraj AJ, et al,. p53 mutations in nonmelanoma skin cancers occurring in psoralen ultraviolet A-treated patients: evidence for heterogeneity and field cancerization. J Invest Dermatol 2002; 119: 522-526.
12. Jonason AS, Kunala S, Price GJ, et al,. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci USA 1996; 93: 14025-14029.
13. Kanjilal S, Strom SS, Clayman GL, et al,. p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res 1995; 55: 3604-3609.
14. Stockfleth E, Ferrandiz C, Grob JJ, et al,. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008; 18: 651-659.
15. Bissonnette R,. Chemoprevention of skin cancer with photodynamic therapy. In, Gold MH, ed. Photodynamic Therapy in Dermatology. (, Gold, Michael H, ed.) Springer Science+Business Media, LCC, 2011: 139-147.
16. MC Gillis S, Fein H,. Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Semin Cutan Med Surg 2004; 23: 174-183.
17. Prado R, Francis SO, Mason N, et al,. Nonmelanoma skin cancer chemoprevention. Dermatol Surg 2011; 37: 1566-1578.
18. Ulrich C,. Topical treatment of field cancerization. Cancer Treat Res 2009; 146: 439-446.
19. Apalla Z, Sotiriou E, Chovarda E, et al,. Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study. Br J Dermatol 2010; 162: 171-175.
20. Goldberg LH, Landau JM, Moody MN, et al,. Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer. J Drugs Dermatol 2012; 11: 593-597.
21. Szeimies RM, Torezan L, Niwa A, et al,. Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy. Br J Dermatol 2012; 167: 150-159.
22. Uhoda I, Quatresooz P, Pierand-Franchimont C, et al,. Nudging epidermal field cancerogenesis by imiquimod. Dermatology 2003; 206: 357-360.
23. Stockfleth E, Christophers E, Benninghoff B, et al,. Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment:a long-term follow-up study. Arch Dermatol 2004; 140: 1542.
24. Sharfaei S, Juzenas P, Moan J, et al,. Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice. Arch Dermatol Res 2002; 294: 237-242.
25. Wennberg AM, Stenquist B, Stockfleth E, et al,. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation 2008; 86: 423-429.
26. Wulf HC, Pavel S, Stender I, et al,. Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. Acta Derm Venereol 2006; 86: 25-28.
27. Zane C, Capezzera R, Sala R, et al,. Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin. Lasers Surg Med 2007; 39: 203-209.
28. Stockfleth E, Meyer T, Benninghoff B, et al,. A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 2002; 138: 1498-1502.
29. Stockfleth E, Sterry W, Carey-Yard M, et al,. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. Br J Dermatol 2007; 157 (Suppl. 2): 41-46.
30. Alomar A, Bichel J, McRae S,. Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. Br J Dermatol 2007; 157: 133-141.
31. Krawtchenko N, Roewert-Huber J, Ulrich M, et al,. A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol 2007; 157 (Suppl. 2): 34-40.
32. Sotiriou E, Apalla Z, Maliamani F, et al,. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities. J Eur Acad Dermatol Venereol 2009; 23: 1061-1065.
33. Serra-Guillen C, Nagore E, Hueso L, et al,. A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate. Br J Dermatol 2011; 164: 429-433.
34. Serra-Guillén C, Nagore E, Hueso L, et al,. A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes. J Am Acad Dermatol 2012; 66: e131-e137.
35. Hadley J, Tristani-Firouzi P, Hull C, et al,. Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses. Dermatol Surg 2012; 38: 722-727.